Active, not recruitingPHASE1, PHASE2NCT05739643
Gene Transfer Clinical Trial for Infantile and Late Infantile Krabbe Disease Treated Previously With HSCT
Studying Infantile Krabbe disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Forge Biologics, Inc
- Intervention
- FBX-101(biological)
- Enrollment
- 9 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2026
Study locations (3)
- Children's Hospital of Orange County (CHOC), Orange, California, United States
- University of Michigan Hospitals - Michigan Medicine, Ann Arbor, Michigan, United States
- Duke University Medical Center, Durham, North Carolina, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05739643 on ClinicalTrials.gov